Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA

1 Nov 2023

Abstract excerpt

Chronic graft-versus-host disease (cGvHD) is a devastating complication of hematopoietic stem cell transplantation (HSCT). Effective early detection may improve the outcome of cGvHD. The potential utility of circulating cell-free DNA (cfDNA), a sensitive marker for tissue injury, in HSCT and cGvHD remains to be established. Here, cfDNA of prospectively collected plasma samples from HSCT recipients (including both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Hematopoietic Stem Cell Transplantation
Share to Renal Transplantation Outcomes and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38026221
DOI: 10.1016/j.isci.2023.108160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNAPMID 38026221Read ↗

Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkersSemantic proximity Read ↗

Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell TransplantationSemantic proximity Read ↗

Circulating cell-free DNA methylation patterns indicate cellular sources of allograft injury after liver transplantSemantic proximity Read ↗

Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant MonitoringSemantic proximity Read ↗

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read ↗

Identification of tissue-specific cell death using methylation patterns of circulating DNASemantic proximity Read ↗

Systematic Evaluation of Cell Type Deconvolution Methods for Plasma Cell-free DNASemantic proximity Read ↗

Distinct Molecular Processes Mediate Donor-derived Cell-free DNA Release From Kidney Transplants in Different Disease StatesSemantic proximity Read ↗

Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and diseaseSemantic proximity Read ↗

Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq)Semantic proximity Read ↗

MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typingSemantic proximity Read ↗

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.